✦ LIBER ✦

Pediatric Drug Development in Anesthesiology: An FDA Perspective

✍ Scribed by Rappaport, Bob A.; Schultheis, Lex W.; Mathis, Lisa L.; Roca, Rigoberto A.; Simone, Arthur F.; Hertz, Sharon H.

Book ID: 115546265
Publisher: Lippincott Williams and Wilkins
Year: 2006
Tongue: English
Weight: 106 KB
Volume: 103
Category: Article
ISSN: 0003-2999
DOI: 10.1213/01.ane.0000228302.15293.de

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of compliance on drug development

Impact of compliance on drug development:: An FDA perspective

✍ M Cavaillé-Coll 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Predicting Drug–Drug Interactions: An FD

Predicting Drug–Drug Interactions: An FDA Perspective

✍ Lei Zhang; Yuanchao (Derek) Zhang; Ping Zhao; Shiew-Mei Huang 📂 Article 📅 2009 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 155 KB

Dissolution Testing for Generic Drugs: A

Dissolution Testing for Generic Drugs: An FDA Perspective

✍ Om Anand; Lawrence X. Yu; Dale P. Conner; Barbara M. Davit 📂 Article 📅 2011 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 349 KB

An FDA perspective on antiarrhythmic dru

An FDA perspective on antiarrhythmic drugs in phase II trials

✍ Raymond Lipicky 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 331 KB

Nonclinical support of pediatric drug de

Nonclinical support of pediatric drug development in a global context: an industry perspective

✍ Gregg D. Cappon 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Pediatric Cardiac Devices—An FDA Pediatr

Pediatric Cardiac Devices—An FDA Pediatrician’s Perspective of the Challenges and Potential Solutions

✍ Francesca Dolcimascolo 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 58 KB